Features | Partner Sites | Information | LinkXpress
Sign In
JIB
BioConferenceLive
GLOBETECH PUBLISHING

Prototype Ultrasound Bioreactor Assesses Engineers Tissue while Making It

By BiotechDaily International staff writers
Posted on 17 May 2012
Image: Biomedical engineer Jenni Popp with NIST’s prototype bioreactor for tissue engineering. The bioreactor both stimulates and evaluates engineered tissue as it grows (Photo courtesy of Burrus/NIST).
Image: Biomedical engineer Jenni Popp with NIST’s prototype bioreactor for tissue engineering. The bioreactor both stimulates and evaluates engineered tissue as it grows (Photo courtesy of Burrus/NIST).
American scientists have devised a prototype bioreactor--a device for culturing cells to create engineered tissues--that both stimulates and assesses tissue as it grows, simulating natural mechanisms while eliminating the need to stop periodically to snip off samples for analysis. Tissue created in this manner might soon be used to replace, for example, injured or diseased cartilage in the hip and knee.

Conventional techniques for evaluating the development and properties of engineered tissue are time-consuming, destructive and need to be repeated many times. By using ultrasound to monitor tissue during processing without destroying it, the novel bioreactor could be a faster and less expensive alternative.
“Most bioreactors don’t do any type of nondestructive evaluation,” said the US National Institute of Standards and Technology (NIST; Boulder, CO, USA) postdoctoral researcher Jenni Popp, first author of a new article about the instrument, published online April 26, 2012, in the Journal of Medical Devices, and to be published the June 2012 print issue. “Having some sort of ongoing evaluation of the developing tissue is definitely novel.”

Natural cartilage is created by specialized cells that generate large amounts of structural proteins to weave a tough support material called extracellular matrix. Lacking blood vessels, cartilage has limited capability to heal from arthritis, injuries, or other defects. Damage can be treated with drugs or joint replacement but results can be imperfect. Engineered tissue is used in some medical treatments but is not yet a routine option to metal or plastic joint replacements. The NIST bioreactor provides researchers with a noninvasive way to monitor vital structural changes in developing tissue.

The NIST/CU bioreactor can fit inside a standard incubator, which controls temperature and acidity in the growth environment. The bioreactor applies force to stimulate five small cubes of cartilage cells embedded in water-based gels. The mechanical force mimics the natural stimuli needed for the cells to create matrix proteins and develop the structure and properties of real cartilage. Ultrasound techniques monitor tissue changes over time, while a digital video microscope takes images.

Early research indicates the bioreactor both stimulates and monitors development of cells, matrix content, and scaffolds to make three-dimensional (3D) engineered cartilage. The cell-laden gels were stimulated twice daily for an hour. Sulfated glycosaminoglycan (sGAG)--which combines with fibrous proteins to form the extracellular matrix--increased significantly after seven days. This structural change was detected by a significant decrease in ultrasound signals after seven days.
The research described in the article was performed at and led by NIST. The bioreactor is a collaborative project with several investigators from the University of Colorado Boulder (CU; USA) department of chemical and biological engineering.

NIST and CU researchers are continuing to develop ultrasonic measurement methods and plan to conduct longer experiments. The bioreactor is also being used by other academic researchers as a tool for confirming mathematical models of biokinetics, the study of growth and movement in developing tissue.

Related Links:

National Institute of Standards and Technology

University of Colorado Boulder



comments powered by Disqus

Channels

Genomics/Proteomics

view channel

Molecular Pathway Decreases Cell Adhesion and Initiates Metastasis

A recent paper outlined a molecular pathway that enables lung cancer cells to migrate away from the site of the primary tumor and become established in other parts of the body. Investigators at the Salk Institute for Biological Studies (La Jolla, CA, USA) linked a virtual alphabet soup of genes and their protein products... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.